September 2019 – Page 6 – Clinical Trial Results

Dr. Basil Lewis and Dr. Yoseph Rozenman Present: ESC 2019 Wrap-Up in Hebrew

September 2, 2019

Disclosures: TBA

Dr. Hisao Ogawa Presents: ESC 2019 Wrap-Up in Japanese

September 2, 2019

Disclosures: TBA

Dr. Jose Luis Leiva Pons and Dr. Xavier Escudero Present: ESC 2019 Wrap-Up in Spanish

September 2, 2019

Disclosures: TBA

Dr. JD Schwalm and Dr. Adam T. Phillips Discuss: HOPE 4 – Impact on cardiovascular risk of a community-based multi-faceted intervention in individuals with hypertension in 2 middle income countries: The Heart Outcomes Prevention and Evaluation 4 study

September 2, 2019

Disclosures: TBA

Dr. Robert Byrne and Dr. Mamas Mamas Present: ESC 2019 Wrap-Up from the UK/Ireland Perspective

September 2, 2019

Disclosures: TBA

Dr. Dragos Vinereanu and Dr. Dan Gaita Present: ESC 2019 Wrap-Up in Romanian

September 2, 2019

Disclosures: TBA

Dr. Gilles Montalescot and Dr. Adam T. Phillips Discuss: Low-dose rivaroxaban after left atrial appendage closure: The randomized ADRIFT study

September 2, 2019

Disclosures: TBA

Dr. Gilles Montalescot Presents: ESC 2019 Wrap-Up in French

September 2, 2019

Disclosures: TBA

Dr. Kausik Ray and Dr. C. Michael Gibson Discuss: Impact of inclisiran on LDL-C over 18 months in patients with ASCVD or risk-equivalent – Results of the Phase 3 ORION-11 trial – Sponsored by an independent educational grant from The Medicines Company

September 2, 2019

Sponsored by an independent educational grant from The Medicines Company

A Conversation With the President: Dr. Barbara Casadei Shares Vision of ESC – Past, Present & Future

September 2, 2019

Disclosures: TBA